TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
Active, not recruitingN/A

RAD 1601: EDGE Radiosurgery for Intractable Essential Tremor and Tremor-Dominant Parkinson's Disease

To determine the efficacy of frameless Virtual Cone Radiosurgical Thalamotomy for medically refractory tremor resulting from either Essential Tremor or Tremor-Dominant Parkinson's Disease with the Fahn-Tolosa-Marin Tremor Rating Scale (FTMT

Birmingham, Alabama, United StatesView details
Completed

Non-interventional Observational Study on WHO-5 Questionnaire Application in Parkinson's Disease

To assess the predictive value of sequential administration of WHO-5 and MDI (Major Depression Inventory) for the clinical management of Parkinson Disease (PD) patients by * determination of the prevalence of depression in PD patients, bas

Achim, Germany+277 moreView details
TerminatedPhase 3

Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients

Phase 3, international, multicenter, randomized, double-blind, placebo-controlled, parallel-group, 3-arm safety and efficacy study (Part A) with an open-label phase (Part B).

Birmingham, Alabama, United States+70 moreView details
CompletedN/A

The Effect of Clinical Pilates Training on Balance and Postural Control of People With Parkinson's Disease.

Many studies showed that clinical pilates exercises has positive effects on static and dynamic balance of different populations. It was suggested that this type of exercise reduce the risk of falls and physical damage.

Mersin, Turkey (Türkiye)View details
CompletedPhase 2

Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder

Alzheimer's disease (AD) and Parkinson's disease (PD) are currently the leading neurodegenerative disorders. Considering the fact that aged population is rapidly growing, it has become a critical issue to find more effective medications for

Taichung, TaiwanView details
CompletedPhase 1

The Effect of a Wearable Cueing Device on Freezing of Gait in Parkinson's Disease

The CuePeD trial is an intervention trial measuring the effectiveness of a novel treatment for Freezing of Gait (FOG) in Parkinson's disease (PD). The primary intervention is the use of a wearable cueing device (WCD), which detects and resp

Brisbane, Queensland, AustraliaView details
CompletedN/A

STEM-Parkinson's Disease

This is a double-blinded, controlled, and randomized clinical trial (RCT) to establish the safety and efficacy of a non-invasive neuromodulation device for treating symptoms associated with Parkinson's disease.

Scottsdale, Arizona, United States+22 moreView details
CompletedN/A

Genetic Influences on Response to Gait Rehabilitation in Parkinson's Disease

The aging Veteran population, together with high exposure to Agent Orange or other herbicides during military service, has made diseases such as Parkinson's disease (PD), currently affecting more than 80,000 Veterans, a major health issue i

Seattle, Washington, United StatesView details
CompletedN/A

Proactive and Integrated Management and Empowerment in Parkinson's Disease (PRIME-UK): A New Model of Care (PRIME-RCT)

People living with Parkinson's disease experience progressive motor and non-motor symptoms, which negatively impact on health-related quality of life. Symptoms emerge and evolve as the disease progresses.

Bristol, United KingdomView details
RecruitingPhase 3

Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform Trial

Parkinson's disease (PD) is currently the fastest-growing neurological condition globally. It is projected to affect 172,000 people in the UK by 2030,with the current annual cost to the country being \~£3.6 billion.

London, United Kingdom+1 moreView details
CompletedN/A

Education for Adapted Physical Activity in Parkinson's Disease

Parkinson's disease is a progressive disorders characterized by motor and non-motor symptoms. Actual medical treatments are symptomatic and have little efficacy on late stage axial motor symptoms.

Lille, FranceView details
CompletedPhase 2

Randomized, Placebo-Controlled Trial of N-acetylcysteine In Parkinson's Disease Patients: A Pilot Study

This is a study on Parkinson's disease patients, referred to Tohid Hospital of Sanandaj City. The patients receive N-acetylcysteine for one year.

Sanandaj, Kurdistan Province, IranView details
Not yet recruiting

Effects of Cognitive Dual-Task on Gait in Parkinson's Disease

The aim of this study is to evaluate gait in individuals diagnosed with PD under tasks involving different cognitive domains, to compare the results with those of age and sex-matched healthy individuals, and to determine which cognitive fun

Ankara, Turkey (Türkiye)View details
Not yet recruitingN/A

Vibrotactile Coordinated Reset for the Treatment of Post Surgery Refractory Parkinson's Disease Patients

The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on refractory post-surgery PD. vCR will be administered with a device called the Stanford Glove.

Stanford, California, United StatesView details
CompletedPhase 3

Dual Task Practice in Parkinson's Disease

The ability to perform two or more tasks together is impaired in Parkinson's Disease (PD). Based on pilot work we hypothesize that dual tasking is amenable to training in PD and will not compromise safety.

Leuven, Vlaams Brabant, BelgiumView details
RecruitingN/A

A Study of the Efficacy of IAMT as an Assessment Tool for Prediction of Progression of Parkinson's Disease

The primary objective of this proposal is to examine the efficacy of Improvised Active Music Therapy (IAMT) sessions as an early novel tool for cognitive and motor assessment for individuals with Parkinson's Disease (PD) in neurological reh

Waterloo, Ontario, CanadaView details
TerminatedN/A

SHARPEN - Parkinson's Disease Dementia

The purpose of this single arm study is to evaluate the feasibility and safety of treatments with a non-invasive neuromodulation device in adults diagnosed with mild/moderate Parkinson's disease dementia (PDD). A non-invasive device is a de

Boca Raton, Florida, United States+1 moreView details
CompletedPhase 2

A Study to Explore the Safety And Tolerability of Doses of E2007 Up to a Maximum of 8 mg In Patients With Parkinson's Disease Who Experience End-of-Dose Wearing Off Motor Fluctuations

This is a randomized, double-blind, two treatment, two group, parallel group study. Subjects will be randomized to one of two treatment groups (E2007 or Placebo) in a 3 to 1 ratio and receive treatment for a total of ten weeks (Days 1 to 70

Little Rock, Arkansas, United States+9 moreView details
CompletedN/A

Non-invasive Neurostimulation in Parkinson's Disease

In this study, the investigators aim to investigate the effects of non-invasive neurostimulation - low-intensity transcranial electrical stimulation in conjunction with transcranial ultrasound (TUS)- on the motor symptoms associated with Pa

Boston, Massachusetts, United StatesView details
Not yet recruitingPhase 2

A Study to Evaluate Efficacy, Safety and Tolerability of Hydroxychloroquine in Subjects With Parkinson's Disease

The purpose of this study is to determine if hydroxychloroquine is safe to take and whether there is potential for it to slow the progression of PD symptoms. This will be done by comparing how PD symptoms progress throughout the study compa

Ottawa, Ontario, CanadaView details
Load more trials